Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
About Ellipsis: Ellipsis is a privately held drug discovery company with lead candidates in the diagnosis and treatment of Degenerative Neurologic Disorders, specifically Alzheimer’s Disease. In addition, the company has discovery programs in Inflammatory Diseases, including Inflammatory Bowel Disease and Rheumatoid Arthritis. Ellipsis’ central business strategy is to develop therapeutics and diagnostics through early clinical proof (Phase I/II of clinical trials) and partner downstream commercialization and marketing. With future projects, Ellipsis intends to retain the rights to identified compounds through later stages of the discovery and clinical trials process before seeking commercialization ( www.ellipsis.com )
Ellipsis Biotherapeutics Corporation
700 Bay Street Suite 2101, Box 195
Toronto, Ontario M5G 1Z6
Canada
Tel: (416) 586-0281
Fax: (416) 586-0638